Activist Investor Jeff Smith is Buying These 15 SPACs in 2022
In this article, we will look at the 15 SPACs activist investor Jeff Smith is buying in 2022.
Posts Tagged ‘NASDAQ:BIOS’
Is BioScrip Inc. (BIOS) Relatively A Good Stock To Buy?
We hate to say this but, we told you so.
Option Care Health, Inc. (BIOS): Are Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Option Care Health, Inc. (BIOS) A Good Stock To Buy?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Is BioScrip Inc. (BIOS) A Good Stock To Buy?
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Here’s What Hedge Funds Think About BioScrip Inc. (BIOS)
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions...
Here is What Hedge Funds Think About BioScrip Inc. (BIOS)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now
There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals that also pay substantial...
13G Filing: Ardsley Partners and Bioscrip Inc. (BIOS)
Please follow Ardsley Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Ardsley Partners or update its stock holdings...
13G Filing: Venor Capital Management and Bioscrip Inc. (BIOS)
Please follow Venor Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Venor Capital Management or update its...
13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)
Please follow Coliseum Capital (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Coliseum Capital or update its stock holdings...
15 Penny Stocks Poised To Explode According To Hedge Funds
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share...
13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)
this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section...
Hedge Funds Are Selling BioScrip Inc. (BIOS)
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Technically Speaking: BioScrip Inc (BIOS), Hertz Global Holdings, Inc (HTZ) And CVS Health Corp (CVS)
In my "Technically Speaking" analyses, I'll take a look at up to three stocks that have entered into either an overbought or oversold condition.
Bioscrip Inc. (BIOS): Billionaire Mario Gabelli’s GAMCO Investors Slightly Lowers Its Stake
Billionaire Mario Gabelli's GAMCO Investors recently filed an amended Form 13D with the US Securities and Exchange Commission, in which it reported slightly lowering its stake...
Five Cheap Healthcare Stocks Poised to Explode
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization...
Coliseum Capital Adds To Its Stake In BioScrip Inc (BIOS)
Coliseum Capital, managed by Christopher Shackelton and Adam Gray, has recently disclosed an increase in its holding of BioScrip Inc (NASDAQ:BIOS).
High-Flying BioScrip Inc. (BIOS) Registers Insider Buying; Amazon Supplier and Funeral Services Provider Also See Insiders Buy Shares
Corporate insiders, namely executives and Board members, are usually privy to a great deal of up-to-date information about current developments or future prospects at their companies...
Monday Headlines Being Dominated by Facebook, Pfizer, Symantec, More
With the markets on edge over a potential Brexit and the FOMC meeting scheduled for this week, the coming days may be more volatile than expected.
CBRE Group Inc (CBG) Spikes to Record High; Check Out the Top Picks of One of Its Investors Cloud Gate Capital
Brian Newman and David Heller’s Cloud Gate Capital, one of the newest additions to our database of more than 700 top hedge funds, was a big winner on Tuesday as a shareholder...
BioScrip Inc (BIOS): Coliseum Capital’s New Activist Target
Christopher Shackelton and Adam Gray’s Coliseum Capital initiated a new position in BioScrip Inc (NASDAQ:BIOS), according to a recent 13D filing with SEC.
Rosetta Resources, BioScrip Inc, PICO Holdings Inc: Funds Bullish On These Stocks Despite Poor Performance
Ken Griffin’s Citadel Investment Group disclosed a large purchase in Rosetta Resources (NASDAQ:ROSE) this week. According to the 13G Form filed with the U.S.
BioScrip Inc (BIOS): GAMCO Investors Still Bullish and Buys More Shares
GAMCO Investors and other funds managed by Mario Gabelli continue to aggressively add to their holdings in BioScrip Inc (NASDAQ:BIOS), having increased their position by another...
BioScrip Inc (BIOS), Proteon Therapeutics Inc (PRTO): GAMCO Investors and Deerfield Management Are Bullish on These Companies
Mario Gabelli’s GAMCO Investors and James E.
Air Transport Services Group Inc. (ATSG), Nature’s Sunshine Prod. (NATR), and Other Small-Caps Comprise Prescott Group’s Top Q2 Picks
A few days ago, Phil Frohlich’s Prescott Group Capital Management filed its 13F for the second quarter of 2014.
Consonance Capital Management is Fond of Healthcare Stocks
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Mario Gabelli’s Latest Moves: Xyratex Ltd. (XRTX), BioScrip Inc (BIOS), & LIN MEDIA LLC (LIN)
In another round of filing with the Securities and Exchange Commission, Mario Gabelli has revealed his latest moves.
Prescott Group Capital Top Picks: Air Transport Services Group Inc. (ATSG), Nature’s Sunshine Prod. (NATR) & More
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Alan Fournier, Pennant Capital Boost Stake in BioScrip
Alan Fournier's hedge fund, Pennant Capital Management, reported in a new filing boosting its exposure at BioScrip Inc (NASDAQ:BIOS) to some 5.74 million shares, from 1.64 million...
What Hedge Funds Think About Rite Aid Corporation (RAD)
To the average investor, there are many methods market participants can use to watch their holdings. A pair of the most useful are hedge fund and insider trading activity.
Hedge Funds Are Dumping GNC Holdings Inc (GNC)
At the moment, there are tons of methods market participants can use to track publicly traded companies.
Hedge Funds Are Selling CVS Caremark Corporation (CVS)
In today’s marketplace, there are many gauges investors can use to monitor the equity markets. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Is BioScrip Inc. (BIOS) Going to Burn These Hedge Funds?
BioScrip Inc. (NASDAQ:BIOS) was in 16 hedge funds' portfolio at the end of the first quarter of 2013.
PharMerica Corporation (PMC): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the financial world, there are plenty of indicators shareholders can use to monitor the equity markets.
This Metric Says You Are Smart to Sell Walgreen Company (WAG)
Walgreen Company (NYSE:WAG) was in 52 hedge funds' portfolio at the end of the first quarter of 2013.
CVS Caremark Corporation (CVS): Hedge Funds and Insiders Are Bearish, What Should You Do?
Is CVS Caremark Corporation (NYSE:CVS) an outstanding investment right now? The smart money is getting less optimistic.
Hedge Funds Are Selling BioScrip Inc. (BIOS)
BioScrip Inc. (NASDAQ:BIOS) was in 11 hedge funds' portfolio at the end of December. BIOS investors should be aware of a decrease in hedge fund sentiment recently.
